PMGC Holdings’ insider option buys signal confidence in a niche skincare pipeline, yet investors must weigh low valuation and regulatory risks before buying.
Insider Braeden Lichti’s June 2026 purchase of 450,277 PMGC option contracts signals strong confidence in the company’s near‑term upside, offering investors a rare glimpse into insider strategy and potential value despite current market volatility.
PMGC Holdings insider deals reveal a strategy of option‑based director compensation, concentrated executive ownership, and preferred‑stock financing aimed at growth while keeping common equity dilute—key insights for investors tracking its risky yet…